The NF-κB Genomic Landscape in Lymphoblastoid B Cells

Cell Reports

Volumn 8, Issue 5, 2014, Pages 1595-1606

  Zhao, Bo ^a,b   Barrera, Luis A ^a,b,c,d,e   Ersing, Ina ^a,b   Willox, Bradford ^a   Schmidt, Stefanie C S ^a,b   Greenfeld, Hannah ^a   Zhou, Hufeng ^a,b   Mollo, Sarah B ^a,b   Shi, Tommy T ^a   Takasaki, Kaoru ^a   Jiang, Sizun ^a,b   Cahir McFarland, Ellen ^a   Kellis, Manolis ^e   Bulyk, MarthaL ^a,b,c,d   Kieff, Elliott ^a,b   Gewurz, Benjamin E ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD UNIVERSITY   (United States)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; FOXM1 PROTEIN, HUMAN; PROTEIN BINDING; PROTEIN SUBUNIT;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BINDING SITE; CELL MATURATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA PROTEIN COMPLEX; DNA SEQUENCE; ENHANCER REGION; GENE EXPRESSION; GENE SILENCING; GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; LYMPHOCYTE FUNCTION; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN SUBUNIT; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN GENOME; METABOLISM; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

B-LYMPHOCYTES; CELL LINE, TUMOR; ENHANCER ELEMENTS, GENETIC; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENOME, HUMAN; HUMANS; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN SUBUNITS; TRANSCRIPTIONAL ACTIVATION;

EID: 84922515063     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.07.037     Document Type: Article

References (58)

1. Baek S.H., Ohgi K.A., Rose D.W., Koo E.H., Glass C.K., Rosenfeld M.G. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 2002, 110:55-67.
2. Bailey T.L., Boden M., Buske F.A., Frith M., Grant C.E., Clementi L., Ren J., Li W.W., Noble W.S. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 2009, 37:W202-W208.
3. Ben-Neriah Y., Karin M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 2011, 12:715-723.
4. Bonizzi G., Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25:280-288.
5. Cahir-McFarland E.D., Davidson D.M., Schauer S.L., Duong J., Kieff E. NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 2000, 97:6055-6060.
6. Chen F.E., Ghosh G. Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views. Oncogene 1999, 18:6845-6852.
7. Chen X., Müller G.A., Quaas M., Fischer M., Han N., Stutchbury B., Sharrocks A.D., Engeland K. The forkhead transcription factor FOXM1 controls cell cycle-dependent gene expression through an atypical chromatin binding mechanism. Mol. Cell. Biol. 2013, 33:227-236.
8. Ernst J., Kheradpour P., Mikkelsen T.S., Shoresh N., Ward L.D., Epstein C.B., Zhang X., Wang L., Issner R., Coyne M., et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011, 473:43-49.
9. Garber M., Yosef N., Goren A., Raychowdhury R., Thielke A., Guttman M., Robinson J., Minie B., Chevrier N., Itzhaki Z., et al. A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Mol. Cell 2012, 47:810-822.
10. Gerondakis S., Grumont R., Gugasyan R., Wong L., Isomura I., Ho W., Banerjee A. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene 2006, 25:6781-6799.
11. Ghisletti S., Barozzi I., Mietton F., Polletti S., De Santa F., Venturini E., Gregory L., Lonie L., Chew A., Wei C.L., et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 2010, 32:317-328.
12. Green M.R., Aya-Bonilla C., Gandhi M.K., Lea R.A., Wellwood J., Wood P., Marlton P., Griffiths L.R. Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma. Genes Chromosomes Cancer 2011, 50:313-326.
13. Halasi M., Gartel A.L. FOX(M1) news-it is cancer. Mol. Cancer Ther. 2013, 12:245-254.
14. Hayden M.S., Ghosh S. NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012, 26:203-234.
15. Heinz S., Benner C., Spann N., Bertolino E., Lin Y.C., Laslo P., Cheng J.X., Murre C., Singh H., Glass C.K. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 2010, 38:576-589.
16. Heinz S., Romanoski C.E., Benner C., Allison K.A., Kaikkonen M.U., Orozco L.D., Glass C.K. Effect of natural genetic variation on enhancer selection and function. Nature 2013, 503:487-492.
17. Huang T.T., Kudo N., Yoshida M., Miyamoto S. A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes. Proc. Natl. Acad. Sci. USA 2000, 97:1014-1019.
18. Jin F., Li Y., Dixon J.R., Selvaraj S., Ye Z., Lee A.Y., Yen C.A., Schmitt A.D., Espinoza C.A., Ren B. A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature 2013, 503:290-294.
19. Kaileh M., Sen R. NF-κB function in B lymphocytes. Immunol. Rev. 2012, 246:254-271.
20. Kasowski M., Grubert F., Heffelfinger C., Hariharan M., Asabere A., Waszak S.M., Habegger L., Rozowsky J., Shi M., Urban A.E., et al. Variation in transcription factor binding among humans. Science 2010, 328:232-235.
21. Kharchenko P.V., Tolstorukov M.Y., Park P.J. Design and analysis of ChIP-seq experiments for DNA-binding proteins. Nat. Biotechnol. 2008, 26:1351-1359.
22. Kulakovskiy I.V., Boeva V.A., Favorov A.V., Makeev V.J. Deep and wide digging for binding motifs in ChIP-Seq data. Bioinformatics 2010, 26:2622-2623.
23. Landt S.G., Marinov G.K., Kundaje A., Kheradpour P., Pauli F., Batzoglou S., Bernstein B.E., Bickel P., Brown J.B., Cayting P., et al. ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res. 2012, 22:1813-1831.
24. Lefebvre C., Rajbhandari P., Alvarez M.J., Bandaru P., Lim W.K., Sato M., Wang K., Sumazin P., Kustagi M., Bisikirska B.C., et al. A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers. Mol. Syst. Biol. 2010, 6:377.
25. Lenz G., Wright G., Dave S.S., Xiao W., Powell J., Zhao H., Xu W., Tan B., Goldschmidt N., Iqbal J., et al. Stromal gene signatures in large-B-cell lymphomas. N.Engl. J. Med. 2008, 359:2313-2323. Lymphoma/Leukemia Molecular Profiling Project.
26. Leung T.H., Hoffmann A., Baltimore D. One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers. Cell 2004, 118:453-464.
27. Lim C.A., Yao F., Wong J.J., George J., Xu H., Chiu K.P., Sung W.K., Lipovich L., Vega V.B., Chen J., et al. Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation. Mol. Cell 2007, 27:622-635.
28. Lim K.H., Yang Y., Staudt L.M. Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies. Immunol. Rev. 2012, 246:359-378.
29. Liu J., Beller D.I. Distinct pathways for NF-kappa B regulation areassociated with aberrant macrophage IL-12 production in lupus- and diabetes-prone mouse strains. J.Immunol. 2003, 170:4489-4496.
30. Longnecker R., Kieff E., Cohen J.I. Epstein-Barr Virus. Fields Virology 2013, Chapter 61:1898-1959. Lippincott, Williams and Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
31. Martone R., Euskirchen G., Bertone P., Hartman S., Royce T.E., Luscombe N.M., Rinn J.L., Nelson F.K., Miller P., Gerstein M., et al. Distribution of NF-kappaB-binding sites across human chromosome 22. Proc. Natl. Acad. Sci. USA 2003, 100:12247-12252.
32. McLean C.Y., Bristor D., Hiller M., Clarke S.L., Schaar B.T., Lowe C.B., Wenger A.M., Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 2010, 28:495-501.
33. Merkenschlager M., Odom D.T. CTCF and cohesin: linking gene regulatory elements with their targets. Cell 2013, 152:1285-1297.
34. Müller C.W., Rey F.A., Sodeoka M., Verdine G.L., Harrison S.C. Structure of the NF-kappa B p50 homodimer bound to DNA. Nature 1995, 373:311-317.
35. Natoli G. Control of NF-kappaB-dependent transcriptional responses by chromatin organization. Cold Spring Harb. Perspect. Biol. 2009, 1:a000224.
36. Natoli G., Saccani S., Bosisio D., Marazzi I. Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat. Immunol. 2005, 6:439-445.
37. Nissen R.M., Yamamoto K.R. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 2000, 14:2314-2329.
38. Ochiai K., Maienschein-Cline M., Simonetti G., Chen J., Rosenthal R., Brink R., Chong A.S., Klein U., Dinner A.R., Singh H., Sciammas R. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity 2013, 38:918-929.
39. Oeckinghaus A., Hayden M.S., Ghosh S. Crosstalk in NF-κB signaling pathways. Nat. Immunol. 2011, 12:695-708.
40. Rahman M.M., McFadden G. Modulation of NF-κB signalling by microbial pathogens. Nat. Rev. Microbiol. 2011, 9:291-306.
41. Rodriguez M.S., Thompson J., Hay R.T., Dargemont C. Nuclear retention of IkappaBalpha protects it from signal-induced degradation and inhibits nuclear factor kappaB transcriptional activation. J.Biol. Chem. 1999, 274:9108-9115.
42. Saccani S., Pantano S., Natoli G. Modulation of NF-kappaB activity by exchange of dimers. Mol. Cell 2003, 11:1563-1574.
43. Sadasivam S., Duan S., DeCaprio J.A. The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression. Genes Dev. 2012, 26:474-489.
44. Schreiber J., Jenner R.G., Murray H.L., Gerber G.K., Gifford D.K., Young R.A. Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. Proc. Natl. Acad. Sci. USA 2006, 103:5899-5904.
45. Sen R., Smale S.T. Selectivity of the NF-κB response. Cold Spring Harb. Perspect. Biol. 2010, 2:a000257.
46. Shih V.F., Tsui R., Caldwell A., Hoffmann A. A single NFκB system for both canonical and non-canonical signaling. Cell Res. 2011, 21:86-102.
47. Siggers T., Chang A.B., Teixeira A., Wong D., Williams K.J., Ahmed B., Ragoussis J., Udalova I.A., Smale S.T., Bulyk M.L. Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-κB family DNA binding. Nat. Immunol. 2012, 13:95-102.
48. Smale S.T. Hierarchies of NF-κB target-gene regulation. Nat. Immunol. 2011, 12:689-694.
49. Sun S.C. Non-canonical NF-κB signaling pathway. Cell Res. 2011, 21:71-85.
50. Tompkins V.S., Han S.S., Olivier A., Syrbu S., Bair T., Button A., Jacobus L., Wang Z., Lifton S., Raychaudhuri P., et al. Identification of candidate B-lymphoma genes by cross-species gene expression profiling. PLoS One 2013, 8:e76889.
51. Uddin S., Hussain A.R., Ahmed M., Siddiqui K., Al-Dayel F., Bavi P., Al-Kuraya K.S. Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma. Haematologica 2012, 97:1092-1100.
52. Wan F., Lenardo M.J. The nuclear signaling of NF-kappaB: current knowledge, new insights, and future perspectives. Cell Res. 2010, 20:24-33.
53. Wang W., Tam W.F., Hughes C.C., Rath S., Sen R. c-Rel is atarget of pentoxifylline-mediated inhibition of T lymphocyte activation. Immunity 1997, 6:165-174.
54. Wang I.C., Ustiyan V., Zhang Y., Cai Y., Kalin T.V., Kalinichenko V.V. Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic Kras(G12D.). Oncogene 2013, Published online November 11, 2013. 10.1038/onc.2013.
55. Yamazaki T., Kurosaki T. Contribution of BCAP to maintenance of mature B cells through c-Rel. Nat. Immunol. 2003, 4:780-786.
56. Ye T., Krebs A.R., Choukrallah M.A., Keime C., Plewniak F., Davidson I., Tora L. seqMINER: an integrated ChIP-seq data interpretation platform. Nucleic Acids Res. 2011, 39:e35.
57. Zarnegar B., He J.Q., Oganesyan G., Hoffmann A., Baltimore D., Cheng G. Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways. Proc. Natl. Acad. Sci. USA 2004, 101:8108-8113.
58. Zhao B., Zou J., Wang H., Johannsen E., Peng C.W., Quackenbush J., Mar J.C., Morton C.C., Freedman M.L., Blacklow S.C., et al. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc. Natl. Acad. Sci. USA 2011, 108:14902-14907.